Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1α independent proliferation by Peeters, Annelies et al.
  
1 
 
 
Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, 
depleted DNA, and PGC-1α independent proliferation 
Annelies Peeters
1
*, Abhijit Babaji Shinde
1
*, Ruud Dirkx
1
*, Joél Smet
2
, Katrien De Bock
3,4
, Marc 
Espeel
5
,
 
Ilse Vanhorebeek
6
, Arnaud Vanlander
2
,  Rudy Van Coster
2
, Peter Carmeliet
3,4
, Marc 
Fransen
7
, Paul P. Van Veldhoven
7
, Myriam Baes
1
 
1
KU Leuven - University of Leuven, Department of Pharmaceutical and Pharmacological Sciences, 
Laboratory of Cell Metabolism, B-3000 Leuven, Belgium 
2
Department of Paediatrics, Division of Paediatric Neurology and Metabolism, University Hospital 
Ghent, B-9000 Ghent, Belgium
 
3
KU Leuven - University of Leuven, Department of Oncology, Laboratory of Angiogenesis and 
Neurovascular Link, B-3000 Leuven, Belgium  
4
VIB, Vesalius Research Center, Laboratory of Angiogenesis and Neurovascular Link, B-3000 Leuven, 
Belgium; 
5
Dept Basic Medical Sciences, UGhent, B-9000 Ghent, Belgium  
6
KU Leuven - University of Leuven, Department of Cellular and Molecular Medicine, Laboratory of 
Intensive Care Medicine, B-3000 Leuven, Belgium 
7
KU Leuven - University of Leuven, Department of Cellular and Molecular Medicine, Laboratory for 
Lipid Biochemistry and Protein Interactions, B-3000 Leuven, Belgium 
*equal contribution 
 
 
Corresponding author: 
Prof. Dr. Myriam Baes  
Laboratory of Cell Metabolism 
Department of Pharmaceutical and Pharmacological Sciences 
Herestraat 49 O/NII box 823 
B-3000  Leuven Belgium 
Tel + 32 16 347283 
Fax +32 16 347291 
e-mail: myriam.baes@pharm.kuleuven.be 
 
 
 
 
 
 
  
2 
 
ABSTRACT 
The tight interrelationship between peroxisomes and mitochondria is illustrated by their cooperation in 
lipid metabolism, antiviral innate immunity and shared use of proteins executing organellar fission. In 
addition, we previously reported that disruption of peroxisome biogenesis in hepatocytes severely 
impacts on mitochondrial integrity, primarily damaging the inner membrane. Here we investigated the 
molecular impairments of the dysfunctional mitochondria in hepatocyte selective Pex5 knockout mice. 
First, by using blue native electrophoresis and in-gel activity stainings we showed that the respiratory 
complexes were differentially affected with reduction of complexes I and III and incomplete assembly 
of complex V, whereas complex II and IV were normally active. This resulted in impaired oxygen 
consumption in cultured Pex5
-/-
 hepatocytes. Second, mitochondrial DNA was depleted causing an 
imbalance in the expression of mitochondrial- and nuclear-encoded subunits of the respiratory chain 
complexes. Third, mitochondrial membranes showed increased permeability and fluidity despite 
reduced content of the polyunsaturated fatty acid docosahexaenoic acid. Fourth, the affected 
mitochondria in peroxisome deficient hepatocytes displayed increased oxidative stress. Acute deletion 
of PEX5 in vivo using adeno-Cre virus phenocopied these effects, indicating that mitochondrial 
perturbations closely follow the loss of functional peroxisomes in time. Likely to compensate for the 
functional impairments, the volume of the mitochondrial compartment was increased several fold. This 
was not driven by PGC-1α but mediated by activation of PPARα, possibly through c-myc 
overexpression. In conclusion, loss of peroxisomal metabolism in hepatocytes perturbs the 
mitochondrial inner membrane, depletes mitochondrial DNA and causes mitochondrial biogenesis 
independent of PGC-1α. 
KEYWORDS: peroxisomes, mitochondria, mitochondrial DNA, oxidative phosphorylation, biogenesis, 
PPARα, PGC-1α 
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INTRODUCTION 
Over the years, it has become clear that peroxisomes and mitochondria have a strong interrelation as 
they exhibit complementary activities, share proteins and communicate with each other.   
Metabolically, both organelles are involved and cooperate in the degradation of fatty acids [1; 2]. Very 
long and branched chain fatty acids are shortened in peroxisomes, followed by transfer to the 
mitochondria for further breakdown. Some of the enzymes participating in β-oxidation such as alpha-
methylacyl-CoA racemase are targeted to both organelles [3]. Moreover, both peroxisomes and 
mitochondria contribute to the detoxification of oxygen radicals generated in cellular processes [4]. In 
addition, it was recently shown that induction of oxidative stress in peroxisomes affects the 
mitochondrial redox balance via unresolved mechanisms [5]. These organelles also depend on the 
same proteins for the execution of their fission process such as Dlp1, Fis1 and Mff1 [6-9]. A defect in 
Dlp1 can even lead to a combined peroxisomal-mitochondrial disorder [10]. Furthermore, other 
proteins such as MAVS that are involved in antiviral signalling were shown to reside both on the 
peroxisomal and outer mitochondrial membrane [11]. A surprising finding was the existence of an 
intracellular transport route between mitochondria and peroxisomes whereby mitochondria derived 
vesicles can incorporate selected cargo and fuse with peroxisomes [12-14]. 
Another illustration of the tight link between these organelles is that mitochondrial abnormalities arise 
when peroxisomes are dysfunctional. In a few early reports on Zellweger syndrome, the most severe 
peroxisome biogenesis disorder, mitochondrial abnormalities were documented in hepatocytes. These 
changes were not studied in detail but included structural alterations at the inner mitochondrial 
membrane and a reduction in the activities of several complexes of the respiratory chain [15-19]. 
Importantly, in different Zellweger syndrome mouse models generated by disruption of Pex5 [20; 21], 
Pex2 [22], or Pex13 [23], swollen mitochondria with sparse and abnormally shaped cristae were found 
in hepatocytes. 
Mitochondrial anomalies were also recapitulated in a liver-selective Pex5 knockout mouse model (L-
Pex5
-/-
) that survives into adulthood [24]. These mice develop microvesicular steatosis, hepatomegaly, 
and fibrosis. The reduced abundance of cristae was accompanied by impaired activity of complex I, III 
and V as determined by spectrophotometry and by an energetic deficit leading to the activation of the 
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cellular energy sensor AMPK [25]. In contrast, mitochondrial matrix enzymes were more active in 
mutant hepatocytes as shown for citrate synthase [24] and mitochondrial β-oxidation [26].  
At present, the mechanisms through which peroxisomal inactivity detrimentally impacts on 
mitochondrial structure and function are unresolved. In order gain insight into these intriguing 
organellar interactions, we have investigated in more detail the properties of the aberrant mitochondria 
in peroxisome deficient hepatocytes, including the expression of the respiratory complexes, redox 
state, lipid composition, fluidity and permeability of the membranes, and DNA content. Furthermore, 
the time course of mitochondrial impairments was investigated by acutely deleting PEX5 from 
hepatocytes. Finally, we investigated whether and how compensatory mitochondrial proliferation is 
activated.  
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MATERIALS AND METHODS 
Mouse breeding 
L-Pex5
-/-
 mice were generated by crossing Albumin-Cre and Pex5
FL/FL
 mice as previously described 
[24]. All experiments were performed on 8-15-week-old Pex5
FL/FL
, considered as controls and 
littermate L-Pex5
-/-
 mice, unless otherwise stated. Pex5
FL/FL
 mice were also brought into a PPARα 
deficient background (provided by Prof. F. Gonzalez [27]). In some experiments Pex5  was acutely 
inactivated in hepatocytes by intravenous administration of adenovirus encoding Cre-recombinase 
(3.10
9
 pfu) or control adenovirus in Pex5
FL/FL
 PPARα
-/-
 or Pex5
FL/FL
 PPARα
+/+
 as previously described 
[25]. Mice were maintained on a 12-hour light/12-hour dark schedule and were fed a standard rodent 
food chow and water ad libitum. All animal experiments were approved by the Institutional Animal 
Ethical Committee of the University of Leuven.  
Analysis of mitochondria 
Purification of mitochondria 
L-Pex5
-/-
 and wild-type mice were killed by cervical dislocation and livers were rapidly removed, 
washed in ice-cold homogenization medium (HM) (0.25 M sucrose, 5 mM Mops, 1 mM EDTA, 0.1% 
(v/v) ethanol, pH 7.2), minced and homogenized in a Potter homogenizer with a motor-driven pestle 
(1200 rpm). Cellular debris was pelleted by centrifugation of the homogenate at 770g for 10 minutes. 
The post-nuclear supernatant (PNS) was spun for 10 minutes at 2330g and the pellet was washed 
once to obtain a fraction enriched in mitochondria. For some experiments, this fraction, corresponding 
to 1.5 g of liver, was layered on top of a Percoll solution (40% (w/v) Percoll, 0.22 M sucrose, 1 mM 
Mops, 1 mM EDTA, 0.1 % (v/v) ethanol, pH7.2) and centrifuged for 1 h at 4°C at 34,000g (Beckmann 
ultracentrifuge) as described before [28] but using only 18 ml of Percoll solution. Subsequently, 500 µl 
fractions were collected starting from the bottom. The distribution of the organelles was monitored by 
measurement of marker enzymes [mitochondria (glutamate dehydrogenase, GDH); lysosomes (acid 
phosphatase); endoplasmic reticulum (glucose-6-phosphatase)]. Mitochondrial enzymes were 
recovered in fractions 2-22 of the 38 fractions that were collected. The 5 fractions containing the 
highest activity of the mitochondrial marker enzyme GDH were combined, diluted 20 times in HM, and 
centrifuged (10 min, 4°C, 2330g). Based on Western blot and EM analysis these fractions primarily 
contained mitochondria and were only contaminated to a minor extent with peroxisomes, ER or 
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lysosomes.  The purified mitochondrial pellet was resuspended in 1 ml of HM and used immediately or 
stored at -80°C for further analysis. 
Quantification of mitochondria 
Purified mitochondria were counted on a FACSCanto flow cytometer (BD) using BD Trucount
TM
 tubes. 
Electron microscopy on isolated mitochondria 
The Percoll-purified mitochondrial pellet was resuspended in a cell free system (CFS) buffer (10 mM 
HEPES,  220 mM mannitol, 68 mM sucrose, 2 mM NaCl, 5 mM pyruvate, 0.5 mM EGTA, 2 mM MgCl2, 
2.5 mM KH2PO4, pH 7.4), centrifuged for 3 min, and fixed in freshly prepared 4% (w/w) glutaraldehyde 
and 8% (w/v) BSA in CFS buffer for 30 minutes on ice. The pellet was washed with sodium cacodylate 
buffer supplemented with 1% (w/v) CaCl2 and prepared for electron microscopy. 
Blue native gel electrophoresis of the oxidative phosphorylation (OXPHOS) complexes 
Blue native gel electrophoresis followed by in-gel activity staining was performed as described [29] on 
isolated liver mitochondria. Samples of controls and knockouts were loaded in duplicate (60 µg/lane). 
In the first set of lanes, activity staining of complex I, III and IV was performed, and the second set of 
lanes was used for the activity staining of complexes II and V. The bands resulting from the complex I, 
II, III and IV activities were scanned in transmission mode. The complex V band, which was seen as a 
white precipitate, was scanned in 'reflexion' mode using a dark background for better visualization [29]. 
Mitochondrial transmembrane potential 
The membrane potential of purified mitochondria was analyzed essentially as in [30]. Briefly, purified 
mitochondrial suspensions were incubated in medium (110 mM KCl, 75 mM mannitol, 20 mM MOPS, 
10 mM glutamate, 1 mM malate, 1 mM EGTA, albumin 1 mg/ml, pH 7.2) for 1 min at room temperature 
in the dark with JC-1 (1.5 µg/mg protein) in a final volume of 0.5 ml. Suspensions were analyzed 
immediately using a FACSVantage SE flow cytometer (BD) equipped with a single 488 argon laser. 
The filter in front of the fluorescence 1 (FL1) photo multiplier (PMT) transmits at 530 nm and has a 
bandwidth of 30 nm, and the filter used in the FL2 channel transmits at 585 and has a bandwidth of 42 
nm. To analyze mitochondria stained with JC-1, the PMT value of the detector in both FL1 FL2 PMT 
was set at 480 V; FL1–FL2 compensation was 1.6 %, and FL2–FL1 compensation was 30%.  
Measurement of Fluorescence Anisotropy 
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Mitochondrial membrane fluidity was evaluated by fluorescence anisotropy of the mitochondria-bound 
dyes 1,6-diphenyl 1,3,5-hexatriene (DPH) and trimethylammonium (TMA)-DPH according to [31]. 
Freshly prepared mitochondrial suspensions (0.5 mg/ml) were incubated in Standard Incubation 
Medium (SIM; 200 mM sucrose, 10 mM Tris-HCl, 1 mM KH2PO4, 10 µM EGTA, 3 µM rotenone, 0.5 µg 
oligomycine and 5 mM succinate; pH 7.4) either with DPH (50 µM; diluted from a stock solution of 20 
mM (prepared in tetrahydrofurane) with 10 mM Tris-HCl pH 7.4, 150 mM KCl, 1 mM EDTA) or TMA-
DPH (3 µM) for 30 minutes at 37°C, under continuous stirring. Steady-state fluorescence polarization 
was measured in a Hitachi spectrofluometer (ex 366 nm: em 425 nm). The results are expressed as 
anisotropy units (r), where r = (I0/I90)/(I0+2I90). I0 and I90 represent the intensities of light when 
polarizers were in parallel or in perpendicular orientations, respectively. Correction for light scattering 
and intrinsic fluorescence were routinely made by subtracting the signal obtained from identical but 
unlabeled samples and the fluorescence of the buffer plus label alone. 
Lipid analysis 
Lipid extracts were prepared from Percoll purified mitochondria and separated by thin-layer 
chromatography using heptane/ether/acetic acid (70/30/1, v/v) before enzymatic analysis of 
triacylglycerols [32], cholesterol and cholesterylesters [33]. Phospholipids were separated by thin-layer 
chromatography with chloroform/methanol/acetic acid/ formic acid/water (70:30:12:4:2, v/v) as 
developing solvent [34]. Major spots corresponding to phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), cardiolipin (CL), phosphatidylserine (PS) and phosphatidylinositol (PI) 
were visualized with iodine vapour, ninhydrin staining and phosphate staining, scraped and 
phosphorus content was determined. Ceramides were quantified with recombinant ceramide kinase in 
presence of 
32
P-ATP [35; 36]. 
Total fatty acid composition was determined in lipid extracts or in phospholipids extracted from 
scraped silica with chloroform/methanol (1:1,v/v) by acidic transmethylation and gas chromatography 
(SPB-PUFA column; Varian 3800). Individual fatty acids were identified by comparing each peak’s 
retention time to those of external standards, and were expressed as the mol % of total fatty acids. 
Estimation of mitochondrial size 
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EM micrographs of 3 control and L-Pex5 knockout mouse livers at a magnification of 5200 were used 
to measure the mitochondrial surface area using the program ImageJ 2.0 (NIH, USA). The values are 
expressed as Mean ± SEM. 
 
RNA analysis 
Quantitative real-time RT-PCR 
qRT-PCR was performed as described previously [37] using an ABI PRISM 7500 Real Time PCR 
instrument (Applied Biosystems, Lennik, Belgium) and probes labelled with the fluorescent dye FAM 
and quencher TAMRA. Primers and probes were designed using Primer Express Software (Applied 
Biosystems, Lennik, Belgium) (Supplemental Table 1). Relative expression levels of the target genes 
were calculated taking into account the amplification efficiency as described [38]. The relative 
expression levels of the target genes were calculated as a ratio to the housekeeping gene β-actin.  
Microarray analysis 
The transcriptional profiles of livers of 10-week-old control and L-Pex5
-/-
 mice (n=3) were analyzed by 
using the whole genome Affymetrix GeneChip
®
 Mouse Genome 430 2.0 Array as described previously 
[39]. Labeling of the samples, hybridization, washing and scanning of the chips was carried out at the 
MicroArray Facility in Leuven (MAF, Leuven, Belgium). The complete dataset is available under GEO 
record GSE27720. 
Mitochondrial DNA copy number 
Nuclear and mitochondrial DNA were isolated from liver tissue using a DNeasy kit (Qiagen). To 
quantify the mitochondrial DNA (mtDNA)/nuclear DNA (nDNA) ratio, qPCR analysis was performed 
using primers and probes for the gene encoding mitochondrial 16S ribosomal RNA and nuclear   
encoded Mpeg, a gene expressed in macrophages (Supplemental Table 1).  
Protein analysis 
Western blotting 
Western blotting was performed as described previously [40]. HRP-labeled secondary antibodies were 
used and detection was performed using the ECL plus detection kit (Amersham). The following 
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primary antibodies were used: COX1 (Mitosciences, Abcam), TOM20 (Santa Cruz), VDAC1 (Cell 
Signaling) and β-actin (Cell Signaling).  
Enzyme activity  
Glutamate dehydrogenase (GDH), complex I and citrate synthase activities were measured in liver 
homogenates as described [24]. In order to evaluate the quality/integrity of the Percoll-purified 
mitochondria, GDH activity was measured in the presence and absence of detergent. For total GDH 
activities, mitochondria were pre-incubated with 0.017% CHAPS (3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate) for one minute to destroy mitochondrial 
membrane barriers.  
In vitro analysis 
Isolation of primary hepatocytes 
Hepatocytes were isolated using a two-step collagenase perfusion technique, plated, and cultured as 
previously described [26]. For some experiments, primary hepatocytes were infected either 4 hours 
after plating with adenovirus encoding PGC-1α (MOI=30) [25] or before plating with lentivirus encoding 
mitochondrial roGFP2 (mt-roGFP2) (MOI=5). 
Extracellular flux analysis 
Primary hepatocytes, plated at 10,000 cells per well, were analyzed 24h after plating using a Seahorse 
XF24 flux analyzer (Seahorse Bioscience) as previously described [41]. Oxygen consumption rate 
(OCR), a measure for electron transport and oxidative phosphorylation, was recorded. 
Redox state of mitochondria 
Isolated primary hepatocytes from control and L-Pex5
-/-
 mice were cultured in 35 mm FluoroDishes 
(World Precision Instruments, Hertfordshire, England), at a density of 0.5 million cells/dish. To 
measure superoxide content, hepatocytes were stained after 24 hours with MitoSOX Red (5 µM, 15 
minutes), washed with PBS, and subsequently incubated with MitoTracker Green (250 nM, 20 
minutes) at 37°C in growth medium. After washing with PBS, medium was refreshed and images were 
acquired immediately. Absorption/emission maxima for MitoSOX Red and MitoTracker Green were 
510/580 nm and 490/516 nm, respectively. As MitoTracker Green stains all the mitochondria 
irrespective of their redox or membrane potential, the ratio of fluorescent intensities of MitoSOX 
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Red/MitoTracker Green was used for normalization purposes. In two independent experiments, 10 
different cells of each genotype were evaluated in which 10 regions of interest per cell were selected.  
To monitor the mitochondrial glutathione redox state a lentiviral vector encoding mt-roGFP2 was 
generated based on a template provided by Dr. Jim Remington (University of Oregon)[42]. Isolated 
hepatocytes from control and L-Pex5
-/-
 mice were transduced immediately after isolation at a MOI of 5 
and cultured in 35/14 mm glass bottom dishes (MatTek corporation, Ashland, USA). After 24 hours, 
media were refreshed and – 24 hours later - images were acquired at the excitation wavelengths of 
400 and 480 nm as described elsewhere [5] . The ratio of fluorescent intensities at 400 to 480 nm can 
be used as a readout of the glutathione redox environment in the organelle. In three independent 
experiments, 10-15 different cells of each genotype were evaluated in which 10 regions of interest per 
cell were selected. 
All the images were acquired with a motorized inverted IX-81 microscope connected to a CCD-FV2T 
digital camera (Olympus, Aartselaar, Belgium) and analyzed as previously described [5]. 
Statistics 
The unpaired two-sided Student’s t-test or two-way ANOVA followed by Bonferroni was used to 
compare the results obtained for both groups of mice. 
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RESULTS 
Defective respiratory chain complexes I, III and V cause impaired mitochondrial respiration in 
L-Pex5 knockout hepatocytes 
We previously determined by spectrophotometric analyses that the ultrastructural anomalies of the 
mitochondrial inner membrane in livers of L-Pex5
-/-
 mice were accompanied by profoundly impaired 
activities of complex I (to ~ 20% of control), mild reduction of complex III and V (~ 60% of control), 
whereas complex II and IV were unaltered [24]. This raised the question whether the affected 
respiratory complexes were present but not functional, or alternatively, whether the assembly/stability 
of these complexes was compromised. To visualize OXPHOS complexes, blue native gel 
electrophoresis was performed on isolated liver mitochondria. This revealed a reduction in protein 
levels of complex I, III and V in the L-Pex5
-/- 
livers (Figure 1a) whereas the protein bands of complex II 
and complex IV were hardly detectable in both wild-type and knockout mitochondria (Figure 1a).  
To better visualize the complexes and monitor their functionality, in-gel activity stainings were 
conducted. In agreement with the spectrophotometric analyses, complex II (Figure 1b right panel) and 
IV (Figure 1b left panel) showed substantial in-gel activity in the knockout liver although the mobility of 
these complexes was reduced. Furthermore, the activity of complex III was undetectable in 
mitochondria from L-Pex5
-/- 
livers whereas this was low but clearly present in mitochondria from 
control mice (Figure 1b left panel). Surprisingly however, although the in-gel activity analyses do not 
allow precise quantification, complex I activity was only moderately reduced, which is in contrast to the 
spectrophotometric data. An additional striking finding was that complex V activity was primarily 
present in several catalytically active subcomplexes (Figure 1b right panel). Such F1 subcomplexes 
were previously found in patients with mitochondrial disorders [29; 43]. Notably, F1 subcomplexes can 
be more active than the holo-complex due to the absence of the inhibitor protein IF1 [43]. These data 
indicate that the residual complex V activity, previously measured by spectrophotometric analysis, was 
largely attributable to catalytically active subcomplexes that can synthesize ATP but are unable to 
transport protons.  
To investigate the impact of the respiratory complex impairments on O2 consumption, hepatocytes 
from control and L-Pex5
-/-
 livers were tested in a Seahorse XF24 flux analyzer. Under baseline 
conditions, the oxygen consumption rate (OCR) was significantly lower in L-Pex5
-/-
 than wild-type 
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hepatocytes (Figure 1c). After addition of antimycin A, an inhibitor of complex III that completely 
inhibits mitochondrial respiration, oxygen consumption significantly dropped in wild-type hepatocytes, 
but this inhibitor had little effect on L-Pex5
-/- 
hepatocytes, indicating that mitochondrial respiration was 
already reduced to minimal levels. 
Expression of mitochondrially-encoded subunits and mitochondrial DNA content is impaired 
To investigate the origin of the differential depletion of the respiratory complexes, the expression of a 
selected set of subunits encoded by the nuclear and mitochondrial genome was determined by 
microarray, qRT-PCR and western blot analysis. Based on previously generated microarray data [25; 
44], the transcripts of nuclear-encoded subunits were either unaltered or increased (Supplemental 
Table 2). In contrast, qRT-PCR analysis revealed that transcripts of the mitochondrially-encoded ND1 
(complex I), COX2 (complex IV) and ATP6 (complex V) were all significantly suppressed (Figure 2a). 
This was confirmed at the protein level by reduced expression of COX1 (data not shown). Because a 
concerted decrease of mitochondrially-encoded mRNAs can be the result of a reduction of 
mitochondrial DNA, we determined the ratio of mtDNA/nuclear DNA. In Pex5
-/-
 livers this ratio was 
halved compared to littermate controls (Figure 2b). Taken together, loss of mtDNA impaired the 
expression of mitochondrially-encoded subunits, which contrasts to the normal to increased transcript 
levels of nuclear-encoded subunits. 
The mitochondrial compartment is enlarged in peroxisome deficient liver 
Several observations, including the electron microscopy data showing clusters of mitochondria [24] 
and the increased activity of mitochondrial matrix enzymes [24; 26], suggested that the volume of the 
mitochondrial compartment was increased in hepatocytes of L-Pex5 knockout mice. In order to better 
document this phenomenon, mitochondria were purified by differential and Percoll gradient 
centrifugation. As shown in Figure 3a, the peak of the mitochondrial GDH activity shifted to lower 
density fractions in the knockout preparations, likely reflecting their aberrant morphology. Both from 
control and knockout preparations, we used the five fractions containing the highest GDH activity for 
further experiments.  
The enlargement of the mitochondrial compartment in peroxisome deficient hepatocytes was proven 
by several lines of evidence. First, the pellet containing the mitochondria isolated from Pex5 knockout 
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livers was considerably larger (0.17 ± 0.03 g/g liver vs 0.10 ± 0.01 g/g liver in wild-type; n=6, p<0.05) 
and contained more protein (19 ± 2 mg/g liver vs 12 ± 1.5 mg/g liver for wild-type, n=6, p<0.05) and 
phospholipids (3.6 ± 0.3 µmol/g liver vs 1.4 ± 0.3 µmol/g liver, n=6, p<0.001). Interestingly, the ratio of 
phospholipids/protein was significantly increased (189.9 ± 3.4 nmol/mg proteins for knockout vs 115.6 
± 4.2 nmol/mg proteins for wild-type; n=6, p<0.001), probably pointing to an altered content of the 
mitochondrial compartment. This increase in mass of isolated mitochondria was not caused by a larger 
size of individual mitochondria in the knockout liver as estimated by measuring the surface area of 
mitochondria on electron micrographs (Figure 3b).  Second, counting of purified mitochondria using 
FACS analysis yielded a 3-fold higher number of mitochondria than controls (Figure 3c). Third, in line 
with these findings, microarray analysis revealed increased expression of genes encoding 
mitochondrial matrix (Citrate synthase, Malate dehydrogenase 2, Isocitrate dehydrogenase 2) and 
membrane proteins (including TOM20, TIM10, prohibitin, CPT2), as shown in supplemental Table 2. 
This was further confirmed by a 2-4 fold increase in the activity per g  liver for mitochondrial matrix 
enzymes, GDH and citrate synthase, and the increased protein levels of outer mitochondrial 
membrane proteins TOM20 and VDAC1 using western blot analysis (Figure 3d). Thus, the increased 
number of mitochondria is in sharp contrast with the reduced level of mtDNA/nuclear DNA, implying 
that the amount of DNA per mitochondrion is severely depleted.  
Mitochondria isolated from L-Pex5 knockout mice retain their structural and functional 
abnormalities 
To further characterize the features of isolated mitochondria from peroxisome deficient
 
livers, we 
performed additional structural and functional tests. Electron microscopic analysis of Percoll purified 
mitochondrial fractions revealed that mitochondria from wild-type mice were present in either an 
orthodox or condensed configuration (Figure 4a), reflecting respectively metabolic state III and IV [45-
47]. In contrast, mitochondria from L-Pex5 knockout livers were not found in either conformation. In 
some mitochondria, the matrix was reduced to a concentric ring, and large empty spaces, presumably 
intermembrane space, could be observed (Figure 4a).    
Subsequently, we tested whether Percoll purified mitochondria still showed a reduction of the 
mitochondrial membrane potential, as previously observed in primary hepatocytes from L-Pex5 
knockout mice [24]. After incubating freshly purified mitochondria with JC1, almost all control 
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mitochondria displayed a high membrane potential (Figure 4b). In clear contrast, almost all knockout 
mitochondria emitted a green fluorescent signal, pointing to a low membrane potential. In addition, 
complex I activity measured by spectrophotometric analysis was undetectable in knockout 
mitochondria (wild-type values: 0.125 U/mg protein). Thus, pure mitochondrial fractions retained the 
functional anomalies seen in vivo and in cell culture.  
Purified mitochondria of L-Pex5 knockout mice display increased membrane fluidity 
The shift in the sedimentation of the knockout mitochondria in Percoll gradients reflects a change in 
buoyant density, caused either by changes in the composition and/or by altered permeability of the 
inner membrane. In order to evaluate the integrity of the isolated mitochondria, GDH activity was 
measured in the presence and absence of detergents. A large amount appeared to be non-latent 
(Figure 4c) pointing to changes in the dynamics of the mitochondrial membrane.  
To obtain a more direct readout of the mitochondrial membrane fluidity, we analyzed the changes in 
the steady state fluorescence polarization of mitochondria bound to DPH (a fluorescent dye that is 
readily incorporated in the hydrophobic region of the phospholipid bilayer) or TMA-DPH (a fluorescent 
probe, which becomes incorporated in the membrane surface between the phospholipid headgroups). 
The rotational diffusion freedom of these probes was monitored by measuring the extent of 
depolarization of the exciting polarized light [48]. Percoll-purified knockout mitochondria showed lower 
fluorescence polarisation of DPH as compared to control mitochondria (Figure 4d). Similar results 
were obtained using TMA-DPH (data not shown). These results indicate that the mitochondrial 
membrane fluidity and thus mitochondrial membrane dynamics were abnormally increased in Pex5 
knockout mitochondria.  
The lipid composition of mitochondrial membranes is altered in peroxisome deficient 
hepatocytes 
Since membrane fluidity is strongly influenced by changes in cholesterol content and fatty acid 
composition of the membrane [49-51], lipidomic analysis of the Percoll-purified mitochondria was 
performed. The stoichiometry of the major membrane components was determined. Despite normal 
cholesterol content in total liver, the ratio of cholesterol per phospholipid was decreased in knockout 
compared to control mitochondria (10.0 ± 0.5 vs 12.6 ± 0.6 nmol/ 100 nmol phospholipid; n=4, 
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p<0.05), in line with the increased membrane fluidity. Ceramide levels did however not statistically 
differ between control and knockout mitochondria (82 ± 9 vs 68 ± 13 pmol/nmol phospholipid, 
respectively). Subsequently, we quantified the relative amounts of the different phospholipid classes. 
The proportion of phosphatidylcholine (PC), phosphatidylethanolamine (PE), cardiolipin (CL), 
phosphatidylserine (PS) or phosphatidylinositol (PI) was not significantly altered (Figure 4e). 
Lysophospholipids, known to affect the membrane permeability, were not detected by thin layer 
chromatography. 
Finally, the fatty acid composition of Percoll-purified mitochondria and of the phospholipids PC, PE 
and CL was determined using GC analysis (Supplemental Table 3). In general, the balance between 
saturated, monounsaturated, and polyunsaturated fatty acids did not differ much between control and 
knockout mitochondria. However, some major changes in individual fatty acids were found in all 
samples examined. Docosahexaenoic acid levels (DHA, C22:6n-3) were reduced by 80% in purified 
knockout mitochondria and in all major phospholipid classes. This can be ascribed to the inactivity of 
peroxisomal β-oxidation, necessary for the final step in the synthesis of this compound. This was 
accompanied by a compensatory increase of C18:2 levels. The replacement of a PUFA with a di-
unsaturated fatty acid in fact reduces the double bond index and is in conflict with increased fluidity of 
the mitochondrial membrane.  
Increased oxidative stress in mitochondria of peroxisome deficient hepatocytes 
Malfunctioning of the respiratory chain can be accompanied by altered production of ROS and 
oxidative stress. Previously, we did not find evidence for oxidative stress development in Pex5
-/-
 
hepatocytes based on measurements of peroxide levels with dichlorodihydrofluorescein diacetate in 
isolated hepatocytes [24]. To specifically evaluate the redox state of mitochondria, we now used more 
targeted and specific probes. First, to detect superoxide levels, the most common ROS species 
generated in mitochondria [52], cultured hepatocytes were incubated with MitoSOX Red. This analysis 
revealed that the fluorescence signal was significantly lower in knockout than control mitochondria 
(Figure 5a). However, this is likely due to impaired uptake of the probe in mitochondria as a result of 
the reduced membrane potential. Subsequently, mt-roGFP2, a mitochondrially targeted glutathione 
redox sensor [42], was transduced in mitochondria of control and Pex5
-/-
 hepatocytes by lentiviral 
infection. This analysis showed a significant increase of the mitochondrial redox state in knockout 
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hepatocytes (Figure 5b), indicating that the mitochondrial anomalies were accompanied by increased 
oxidative stress.   
Acute elimination of peroxisomes causes similar mitochondrial alterations 
All the above experiments were performed using livers of adult mice in which peroxisomal function 
was chronically deleted from hepatocytes since birth [24]. To exclude the possibility that these results 
reflected a long-term adaptation to the peroxisome deficiency state, we also acutely eliminated PEX5 
in hepatocytes. This also allowed us to delineate the timing of mitochondrial anomalies subsequent to 
loss of peroxisomal function. To this end adenoviral Cre recombinase was administered to Pex5
FL/FL
 
mice, using previously described methods [25]. Upon deletion of PEX5, no new functional 
peroxisomes can be formed and the existing peroxisomes disappear with an estimated 2-day half-life 
[53]. By monitoring urate oxidase, the activity of which strongly depends on its peroxisomal 
localization, we observed that 7 days after induction of PEX5 deletion, functional peroxisomes had 
partially disappeared. One week later, the majority of hepatocytes was devoid of intact peroxisomes 
(Figure 6a). This was confirmed by the cytosolic staining pattern of the peroxisomal marker enzyme 
catalase (data not shown).  
Analysis of key mitochondrial features revealed that acute depletion of peroxisomes in hepatocytes 
induced similar mitochondrial defects as chronic loss, further highlighting that these defects were 
primary in nature. This analysis revealed that the activity of complex I, measured by 
spectrophotometry, and expression levels of COX2 and ND1 were still normal one week after 
adenoviral Cre administration. However, after two weeks, complex I activity was strongly impaired (2.5 
± 0.2 mU/mg protein after injection of adenoviral Cre-recombinase versus 8.0 ± 0.3 mU/mg protein 
with control virus) (Figure 6b, left columns). In addition, expression of COX2 and ND1 (Figure 6c) and 
the mtDNA abundance (Figure 6d) were significantly decreased at this time point. This was 
accompanied by ultrastructural abnormalities of mitochondria similar to those in L-Pex5 knockout livers 
(data not shown). The mitochondrial anomalies were thus not a long-term adaptation to the absence of 
functional peroxisomes as they occurred rapidly after peroxisome deletion. 
Mitochondrial proliferation in hepatocytes with acute and chronic PEX5 elimination is not 
driven by PGC1α but is mediated by PPARα 
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Given that PGC-1α is a major driver of mitochondrial biogenesis and oxidative capacity in conditions of 
energy deficit by inducing and co-activating crucial transcription factors, it was surprising that transcript 
and protein levels of PGC-1α were reduced ([25] and Figure 7a) in mice with either a chronic or acute 
elimination of PEX5 (30- 50% of WT). To obtain insight in the mechanisms causing the enlargement of 
the mitochondrial compartment, we analyzed the expression of other factors, known to be involved in 
the regulation of mitochondrial proliferation, respiration or transcription [54] by using qRT-PCR 
analysis (Figure 7a) and analysing micro-array data of L-Pex5
-/-
 livers (Supplemental Table 2).  
The expression of the other PGC family members, PGC-1β and PRC1 was unaltered. Also the 
transcription factors NRF-1 and NRF-2 that coordinate the expression of nuclear-encoded 
mitochondrial proteins and the mitochondrial transcriptional machinery, and factors that regulate 
mitochondrial transcription (mitochondrial RNA polymerase and the mitochondrial transcription factor A 
(TFAM), B1 and B2) were not changed to a significant extent. Notably, transcripts of C-MYC, known to  
regulate mitochondrial biogenesis [55], were 7-fold increased in Pex5
-/-
 livers (Figure 7a). Although the 
expression of ERRα was unchanged based on micro-array analysis, a significant 1.6 fold increase was 
noticed by qPCR.  
In order to further substantiate these data, mitochondrial biogenesis was also examined in mouse 
livers with acute elimination of PEX5 using adenoviral Cre recombinase. Notably, mitochondrial 
expansion was already observed two weeks after induction of Pex5 recombination as evident from 
increased activity of citrate synthase (Figure 7b). The expression levels of NRF2 (1.7 fold) and C-MYC 
(3 fold) were significantly increased in these livers (Figure 7c-d), whereas NRF1 and ERRα were 
unaltered (data not shown) and TFAM was even reduced (Figure 7e) (to 70% of control). 
Interestingly, c-myc is known to be induced by PPARα agonists [56] and this nuclear receptor is 
strongly activated in L-Pex5
-/-
 livers [25]. In order to investigate whether PPARα activation was 
involved in the development of the mitochondrial alterations, a mouse strain was generated with 
peroxisome deficient hepatocytes in a PPARα null background. Therefore, adenoviral Cre-
recombinase was administered to PPARα
-/-
Pex5
FL/FL 
mice and, as controls, to PPARα
+/+
Pex5
FL/FL
 mice. 
In the PPARα deficient background, mitochondria were not proliferating at 2 weeks after administering 
Cre recombinase, when functional peroxisomes are eliminated, based on normal citrate synthase 
activity (Figure 7b). Under these circumstances, c-myc transcripts were not increased in PEX5 deleted 
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hepatocytes (Figure 7d), suggesting that both the increase in c-myc and mitochondrial proliferation 
depended on PPARα.  In order to examine whether the mitochondrial functional deficits may also be 
related to PPARα induction, complex I activity was monitored by spectrophotometry. However, 2 
weeks after administering Cre recombinase, loss of PEX5 was accompanied by reduced complex I 
activity that was similar in a PPARα
-/-
 (to 29 ± 7% of control) and a PPARα
+/+
 background (to 31 ± 3 % 
of control). Taken together, the strong PPARα activation in peroxisome deficient hepatocytes does not 
underlie the mitochondrial dysfunction but is involved in the proliferative response. 
. 
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DISCUSSION 
The communication between cellular compartments (like mitochondria and peroxisomes) and their 
interdependence is currently still only poorly understood. We previously documented that peroxisome 
dysfunction in murine Pex5
-/-
 hepatocytes severely impacts on the mitochondrial inner membrane with 
loss and structural changes of cristae and selective impairment of some but not all activities of 
OXPHOS complexes [21; 24]. The key novel findings of our study are: 1) mitochondrial membranes 
displayed altered physicochemical properties; 2) respiratory complexes were differentially depleted or 
incompletely assembled; 3) mtDNA was reduced leading to an imbalance between mitochondrial- and 
nuclear-encoded subunits; and 4) the compensatory increase of the mitochondrial compartment was 
not driven by classical PGC-1α signalling but mediated by PPARα.  
Whereas metabolism in the mitochondrial matrix was preserved and even increased in Pex5
-/-
 
hepatocytes [26], the architecture, function and lipid composition of the inner membrane was severely 
disorganised. By using blue native gel electrophoresis and in-gel activity analysis, we showed that the 
abundance of protein in the respiratory complex I and III was respectively moderately and strongly 
reduced and that the majority of complex V was incompletely assembled. It is remarkable that the 
activity of complex I (NADH:ubiquinone reductase) was decreased to a larger extent using 
spectrophotometric analysis (<30% of controls) than using in-gel activity measurements. However, it 
should be noted that these techniques rely on different enzymatic evaluations of complex I. The 
spectrophotometric assay measures the complete electron transfer in complex I, i.e. from the 
substrate NADH to co-enzyme Q. In contrast, the in-gel activity staining of complex I only evaluates 
the first part of this electron transfer cascade as a hydrogen and electron from NADH are transferred 
to nitro blue tetrazolium by the action of the flavoprotein subunits located at the peripheral arm of 
complex I. Furthermore, it has been demonstrated that the CoQ binding site is situated at the interface 
between the membrane section containing the mtDNA encoded subunits and the peripheral arm of 
complex I. Importantly, also in patients with mutations in mtDNA-encoded subunits of complex I, 
the same discrepancy between these two assays has been reported [57; 58]. Therefore, 
spectrophotometry is better suited to detect defects in the mtDNA encoded subunits of complex I. 
The question arises what the precise sequence of events is at the inner mitochondrial membrane. It is 
indeed unclear whether the loss or assembly defects of the respiratory complex elicited the 
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malformation of cristae or whether membrane anomalies prevented the integration of respiratory 
complexes. With regard to the first possibility, studies in yeast documented that defective complex 
assembly can impair cristae formation. For example, ATP synthase occurs as long rows of dimers at 
cristae ridges and the inability to dimerize results in the formation of mitochondria with onion-like 
cristae [59; 60]. In addition, complete loss of mtDNA in the rho
0
 mutants causes structural 
mitochondrial distortions [61] that remarkably resemble those seen in the isolated mitochondria from 
Pex5 mutant mice. In PEX5 deficient hepatocytes, the mtDNA copy number per mitochondrion was 
estimated to be reduced to approximately 15-20%, taking into account the 50% reduced levels of 
mtDNA/nuclear DNA and the substantial increase in mitochondrial mass (~3 fold). The ensuing 
decreased levels of mitochondrially-encoded OXPHOS subunits is expected to impair the respiratory 
complex assembly, which may in turn compromise cristae formation. In particular, for complex V, the 
two mitochondrially-encoded subunits, a and A6L, are part of the F0 domain embedded in the inner 
membrane and are necessary for the connection with the catalytically active F1 domain [29]. It was 
shown that tissues from patients with mtDNA alterations, including mutations in the mitochondrially-
encoded ATP6 or ATP8 genes, mutations in mitochondrially-encoded tRNA's, specific mtDNA 
deletions and finally with mtDNA depletion, contain catalytically active subcomplexes of complex V 
visible by in-gel ATPase activity analysis [29; 43]. This is similar to our findings in peroxisome-deficient 
hepatocytes where complex V almost exclusively occurs as incomplete subcomplexes concurring with 
the loss of mtDNA. The intact activity of complex II that contains no mitochondrially encoded subunits 
further supports the possibility that mtDNA defects are the source of the anomalies. Conversely, 
complex IV activity was also unaffected when tested by spectrophotometric and in-gel activity analysis 
albeit the mobility seemed to be reduced. Yet, complex IV depends on 3 mtDNA subunits (COX1-3) 
questioning how it can assemble and function properly.  
However, the most pertinent question in this scenario is how inactive peroxisomes can affect mtDNA. 
A possible mechanism is through the production of oxidative stress as it is well known that ROS can 
impair mitochondrial DNA integrity and dysfunctional peroxisomes might be a source of ROS species 
[4]. Interesting in this respect, excessive oxidative stress generated in peroxisomes increases the 
mitochondrial but not the cytosolic redox state [5]. It was also reported that lack of ABCD1, a 
peroxisomal transporter of β-oxidation substrates, causes oxidative damage to mitochondrial proteins 
leading to reduced activity of ATP synthase but not of other OXPHOS complexes in spinal cord [62]. It 
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is, however, unclear whether in conditions of peroxisome biogenesis defects, in which both the ROS 
generating oxidases and the ROS degrading enzymes such as catalase are absent from peroxisomes, 
ROS species are increased in the cell. Previously, we did not find evidence for increased cellular 
oxidative stress in Pex5 deficient hepatocytes [24] whereas we now demonstrated an increase in the 
redox state of mitochondria. Unfortunately, we could not pinpoint whether this derives from local 
superoxide production. Indeed, the fluorescence signal using the MitoSOX Red assay was markedly 
reduced but this may be an underestimation due to the low mitochondrial membrane potential that 
impairs uptake of the probe [63]. In addition, the depletion of mtDNA in Pex5 deficient hepatocytes 
may further weaken the fluorescent signal of the oxidized probe, as this is strongly enhanced by 
binding to DNA [63]. Therefore, it remains an open question whether the increased redox state of 
mitochondria is a cause or a consequence of OXPHOS disturbances.  
In the alternative hypothesis, peroxisome dysfunction initially causes a morphological insult at the 
inner membrane preventing the integration of OXPHOS complexes that subsequently are inactive 
and/or disintegrate. The putative triggering factor could be an imbalance of lipids as a result of 
impaired peroxisomal metabolism. This could for example explain the presence of the catalytically 
active F1 domain of complex V that resides in the matrix while the transmembrane subunits a and A6L 
cannot be incorporated in the membrane due to lipid alterations preventing the formation of the 
holocomplex. The conserved activity of the small complex II, consisting of only 4 subunits and not 
integrally embedded in the inner membrane, could be a notable exception as it may remain stable 
when not properly inserted in the membrane. Again, the normal activity of the large complex IV in 
spectrophotometric analyses is difficult to reconcile with this mechanism as the majority of its subunits 
are transmembrane proteins of the inner membrane.  According to this rationale, the loss of mtDNA 
must also be secondary to the inner membrane perturbation. The mitochondrial genome that is 
packaged in nucleoids [64] is tethered to the inner membrane [65; 66], and it is plausible that the 
extensive distortion of the inner membrane precludes attachment of the mitochondrial genome, 
leading to its loss. Interestingly, in some rare cases of inborn errors of metabolism, mutations in 
enzymes involved in lipid metabolism were shown to cause mitochondrial deficits including loss of 
mtDNA. Examples are MEGDHEL syndrome due to mutations in SERAC1, involved in phospholipid 
remodelling and intracellular cholesterol transport [67], Megaconial Congenital Muscular Dystrophy 
  
22 
 
(MDCMC) caused by choline kinase B deficiency [68] and Sengers syndrome due to a lack of 
acylglycerolkinase [69; 70]. 
The altered mitochondrial membrane features in peroxisome deficient liver are further characterized by 
increased permeability and fluidity. The marked reduction of the poly-unsaturated fatty acid DHA, a 
product of peroxisomal β-oxidation, in all phospholipid species including cardiolipin is in fact in 
disagreement with increased membrane fluidity. However, the decreased cholesterol/phospholipid 
ratio and the loss of respiratory complexes may also contribute to the altered membrane 
characteristics. Another apparently controversial observation is that, despite an extensive loss of the 
potential over the inner membrane previously observed in cultured hepatocytes [24] and now in 
isolated mitochondria, matrix enzymes can still be imported. For example, the mt-roGFP2 probe used 
to study the intramitochondrial redox balance was efficiently imported into the organelle. In addition, 
the activities of the mitochondrial matrix proteins GDH and CS were even increased, reflecting the 
larger mitochondrial mass. Note that these observations are in accordance with previous findings in 
mtDNA-deficient rho
0
 mutants, in which the import and activity of nuclear-encoded proteins is  
unaffected [61].  
Besides enhanced activity of matrix enzymes, the expansion of the mitochondrial compartment in 
peroxisome deficient hepatocytes was also illustrated by increased organelle numbers and by 
increased protein content in the mitochondrial fraction.  This mitochondrial expansion seemed to be a 
compensatory response as was also observed in other conditions of mtDNA depletion [71] or defects 
in mitochondrial respiratory function [72]. Proliferation appeared to be a prompt reaction after acute 
PEX5 elimination as it occurred concomitant with loss of functional peroxisomes and disruption of the 
inner membrane. In view of the strong proliferative response, it is most surprising and puzzling that 
levels of PGC-1α, the master regulator of mitochondrial biogenesis in conditions of energy deficits, are 
markedly reduced [25]. The family members PGC-1β and PGC-1-related coactivator (PRC) were 
normally expressed or only slightly induced, not likely to steer proliferation. Therefore, other factors 
must drive the increased generation of mitochondria. c-MYC is a good candidate as it was reported to 
induce mitochondrial biogenesis [73; 74] and in addition is a PPARα target gene that was strongly 
induced in PEX5 deficient liver. This assumption is supported by the absence of c-myc induction and 
mitochondrial proliferation after acute elimination of PEX5 in a PPARα deficient background. In other 
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conditions of mitochondrial damage [75; 76], increased expression of the transcription factors NRF-
1/NRF-2, that play an integrative role in the bigenomic expression of mitochondrial proteins, and their 
target Tfam, that is essential for mtDNA transcription initiation, was shown to enhance OXPHOS. 
Remarkably, no consistent upregulation of these factors was observed at the RNA level in hepatocytes 
with either acute or chronic deletion of PEX5. Thus, the mechanisms governing the increase of 
mitochondrial volume in peroxisome deficient hepatocytes as a compensation for respiratory 
dysfunction deviate from those in other conditions of cellular energy deficits. In particular, the 
coordinate induction of the mitochondrial and nuclear-encoded proteins seems to fail. At present, it 
cannot be excluded that the enlarged mitochondrial volume is in part also due to impaired mitophagy, 
a possibility that needs investigation.  
In conclusion, we showed that inactive peroxisomes in hepatocytes impact the mitochondrial genome, 
the physicochemical properties of the inner membrane, OXPHOS complexes, and the mitochondrial 
redox state. The triggering factors arising from inactive hepatic peroxisomes and the precise sequence 
of events in the affected mitochondria need to be further clarified. This is of importance as hepatic 
pathology, including hepatomegaly and fibrosis, is a cardinal feature in Zellweger syndrome, the 
prototype peroxisome biogenesis disorder. This hepatopathy may originate from the mitochondrial and 
not peroxisomal metabolic deficits. 
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FIGURE LEGENDS 
Figure 1: Differential reduction of OXPHOS complexes causes impaired respiration in Pex5
-/- 
hepatocytes.  
a: Blue native gel electrophoresis shows reduced protein levels of complex I, III and V in Pex5
-/-
 liver 
mitochondria (red arrows). Lane M contains a human skeletal muscle control sample. Complex II and 
IV are difficult to identify in the liver samples and run with slightly lower mobility as compared to the 
muscle sample. Representative experiment out of 2 with similar results b: In-gel activity staining of 
respiratory complexes. Left: the function of complex I is moderately reduced whereas complex III is not 
detectable in Pex5
-/-
 liver mitochondria. The blue band above complex III in the control samples 
represents complex V from the Coomassie staining after blue native electrophoresis. Complex IV is 
active but displays impaired mobility. Right: the majority of complex V activity is present in lower MW 
subcomplexes (red arrows) while complex II displays normal function but slightly impaired and variable 
mobility. Representative experiment out of 4 with similar results c: Oxygen consumption was 
measured in primary hepatocytes. The profiles shown are from 1 experiment in which 10 replicate 
wells were monitored from either wild type or Pex5
-/-
 hepatocytes. Pex5
-/-
 hepatocytes consume less 
oxygen and oxygen consumption is insensitive to the complex III inhibitor antimycin A. Values are 
shown as mean ± SEM. p<0.001: ***; p<0.01: ** L-Pex5
-/-
 versus control mice. 
Figure 2: Reduced expression of mitochondrial-encoded subunits of OXPHOS complexes and 
of mtDNA in L-Pex5
-/-
 mice.  
a: Transcript levels of the mitochondrial-encoded subunits ND1 (complex I), COX2 (complex IV) and 
ATP6 (complex V) were significantly lower in Pex5
-/-
 livers as compared to controls (Ct). b: 
Mitochondrial DNA copy number, relative to genomic DNA, was reduced in Pex5
-/-
 livers. Values are 
shown as mean ± SEM for n ≥ 4. p<0.001: ***; p<0.01: **; p<0.05: * L-Pex5
-/-
 versus control mice.  
Figure 3: The mitochondrial compartment is enlarged in L-Pex5
-/-
 mice.  
a: Percoll gradient of mitochondrial-enriched fraction obtained by differential centrifugation of livers 
from control (Ct) and L-Pex5
-/-
 liver.  The GDH-activity in the first 22 Percoll fractions is shown in U/mg 
protein. The total GDH-activity was increased in isolated mitochondria of L-Pex5
-/-
 mice and the peak 
of GDH activity shifted towards lower density fractions (1 representative experiment out of 4 is shown). 
b: Mitochondrial area was estimated on electron micrographs at a magnification of 5200 fold by using 
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the ImageJ program. All values are represented as mean ± SEM of arbitrary units (n= 260 and 160 
mitochondria from 3 independent mice from control and L-Pex5 knockout mice respectively, p<0.05); 
c: Mitochondrial number, determined by FACS analysis, was strongly increased in L-Pex5
-/-
 mice. 
Values shown are mean ± SEM (n = 4,  *: p<0.05) d: Western blot analysis of the outer mitochondrial 
membrane proteins TOM20 and VDAC1 shows increased expression relative to β-actin in L-Pex5
-/-
 
liver as compared to control. Numbers at the top of the blots indicate the fold change as quantified 
after normalization with β-actin. All values are shown as mean ± SEM (n = 3). p<0.01: **; p<0.05: * L-
Pex5
-/-
 versus control mice. 
Figure 4: Characteristics of Percoll-purified mitochondria of L-Pex5
-/-
 mice.  
a: EM analysis of GDH-enriched Percoll fractions. Wild-type mitochondria are either in the condensed 
or orthodox state (marked with X in Ct), while none of the mitochondria from mutant hepatocytes can 
be found in either state. Unusual conformations of mitochondria from mutant liver are marked with X. 
b: FACS-scan analysis of the mitochondrial membrane potential. The majority of the wild-type 
mitochondria display a red fluorescence, while KO mitochondria mainly display a green fluorescent 
signal. The data in this figure are from one experiment out of 4 with similar results. c: Non-latent 
activity measurement of GDH. Values are expressed as % of total GDH-activity ± SEM (n=5). d: 
Anisotropy measurements using DPH as fluorescent probe shows increased fluidity of mitochondrial 
membranes from L-Pex5
-/-
 mice (n=3). e: The phospholipid composition of mitochondria is not 
significantly different in L-Pex5
-/-
 compared to control mice. Values are expressed relative to the total 
amount of phospholipids ± SEM (n=4). PC: phosphatidylcholine, PI: phosphatidylinositol, PS: 
phosphatidylserine, PE: phosphatidylethanolamine, CL: cardiolipin. p<0.001: ***; p<0.05: * L-Pex5
-/-
 
versus control mice.  
Figure 5: Increased redox state of mitochondria in peroxisome-deficient hepatocytes 
a: Ratio of fluorescent intensities of MitoSOX Red (MSR) to mitotracker green (MTG) in primary 
hepatocytes isolated from control (Ct) and L-Pex5
-/- 
mice (n≥200 regions of interest for each genotype 
derived from 2 independent experiments). b: Increased mitochondrial glutathione redox balance in L-
Pex5
-/- 
primary hepatocytes compared to control hepatocytes as observed by the ratio of fluorescence 
intensities at 400 and 480 excitation wavelengths of mt-roGFP2 (n≥450 regions of interest for each 
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genotype derived from 3 independent experiments). Values are expressed as mean ± SEM. p<0.001: 
*** L-Pex5
-/-
 versus control mice. 
Figure 6: Acute deletion of PEX5 affects the respiratory chain and mtDNA  
a: The declining activity of urate oxidase in liver homogenates of Pex5
FL/FL
 mice 7 and 14 days after 
administration of adenoviral Cre versus control virus is indicative of impaired peroxisomal function. b-
d: Analyses of mitochondrial markers in liver of Pex5
FL/FL
 mice 14 days after administration of 
adenoviral Cre or control virus. The activity of complex I (b), transcript levels of the mitochondrial-
encoded subunits COX2 and ND1 (c) and the ratio of mtDNA/nuclear DNA (d) was significantly 
decreased in mice treated with adenoviral Cre. Values are expressed as mean ± SEM. p<0.001: ***; 
p<0.05: * control virus versus adenoviral Cre.  
 Figure 7: Mitochondrial proliferation in L-Pex5
-/-
 livers occurs despite reduced levels of PGC-
1α but depends on PPARα 
a: qRT-PCR analysis of key regulators of mitochondrial biogenesis and transcription in L-Pex5
-/-
 mice 
with chronic deletion of PEX5. b: Citrate synthase activity is increased 14 days after acute deletion of 
PEX5 with adenoviral Cre recombinase in Pex5
FL/FL
 mice but not in a PPARα
-/-
 background indicating 
that mitochondrial proliferation depends on PPARα. c-e: qRT-PCR analysis of regulators of 
mitochondrial biogenesis and transcription in PPARα
+/+
Pex5
FL/FL
 or PPARα
-/-
Pex5
FL/FL
 mice 14 days 
after administering adenoviral Cre recombinase. All values are shown as mean ± SEM (n=4) p<0.001: 
***; p<0.01: **; p<0.05: * knockout versus respective control mice. 
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